193 related articles for article (PubMed ID: 19704946)
1. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte antibody-dependent cytotoxicity test for evaluation of clinical role of monoclonal anti-D-antibodies for prevention of rhesus sensitization.
Olovnikova NI; Belkina EV; Nikolaeva TL; Miterev GY; Chertkov IL
Bull Exp Biol Med; 2006 Jan; 141(1):57-61. PubMed ID: 16929965
[TBL] [Abstract][Full Text] [Related]
3. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
[TBL] [Abstract][Full Text] [Related]
4. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal anti-D development programme.
Kumpel BM
Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
[TBL] [Abstract][Full Text] [Related]
6. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
Kumpel BM
Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
[TBL] [Abstract][Full Text] [Related]
7. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro.
Wiener E; Dellow RA; Mawas F; Rodeck CH
Transfus Med; 1996 Sep; 6(3):235-41. PubMed ID: 8885153
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
[TBL] [Abstract][Full Text] [Related]
9. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
10. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D.
Hadley AG; Kumpel BM
Vox Sang; 1989; 57(2):150-1. PubMed ID: 2506695
[No Abstract] [Full Text] [Related]
12. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).
Kumpel BM; De Haas M; Koene HR; Van De Winkel JG; Goodrick MJ
Clin Exp Immunol; 2003 Apr; 132(1):81-6. PubMed ID: 12653840
[TBL] [Abstract][Full Text] [Related]
13. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
[TBL] [Abstract][Full Text] [Related]
14. IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model.
Bernardo L; Yu H; Amash A; Zimring JC; Lazarus AH
J Immunol; 2015 Sep; 195(5):2224-30. PubMed ID: 26188060
[TBL] [Abstract][Full Text] [Related]
15. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
[TBL] [Abstract][Full Text] [Related]
16. Shedding of Fc receptor from mononuclear cells and their ability of binding IgG1 and IgG3 anti-Rh/D antibodies.
Maślanka K; Erdei A
Arch Immunol Ther Exp (Warsz); 1988; 36(1):15-22. PubMed ID: 3148299
[TBL] [Abstract][Full Text] [Related]
17. Ability of monoclonal anti-D antibodies to promote the binding of red cells to lymphocytes, granulocytes and monocytes.
Merry AH; Brojer E; Zupanska B; Hadley AG; Kumpel BM; Hughes-Jones NC
Vox Sang; 1989; 56(1):48-53. PubMed ID: 2492701
[TBL] [Abstract][Full Text] [Related]
18. [Absence of relation between activity of mono- and polyclonal anti-rhesus immunoglobulins in in vitro and in vivo tests].
Olovnikova NI; Belkina EV; Nikolaeva TL; Chertkov IL
Biull Eksp Biol Med; 1998 Jan; 125(1):71-4. PubMed ID: 9532373
[No Abstract] [Full Text] [Related]
19. Further investigation of nonspecific biological substance in anti-Rh(D) preparations.
Petri IB; Lörincz A; Berek I
Vox Sang; 1986; 51(4):287-91. PubMed ID: 2948323
[TBL] [Abstract][Full Text] [Related]
20. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
León-González G; Cruz C
Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
